Press Releases
-
2023-01-16Kancera reports that the FRACTAL-study is on track to report top line results in Q3 2023
-
2022-12-22Kancera submits regulatory application to conduct clinical study in ovarian cancer and enters into collaboration with the Nordic Society of Gynaecological Oncology
-
2022-10-27Interim report third quarter, January 1 – September 30, 2022, Kancera ab (publ.), org.nr. 556806-8851